BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8985270)

  • 1. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma.
    Kumada T; Nakano S; Takeda I; Sugiyama K; Osada T; Kiriyama S; Sone Y; Toyoda H; Shimada S; Takahashi M; Sassa T
    Hepatology; 1997 Jan; 25(1):87-92. PubMed ID: 8985270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of solitary small hepatocellular carcinoma: consideration of hepatic functional reserve and mode of recurrence.
    Horigome H; Nomura T; Nakao H; Saso K; Takahashi Y; Akita S; Sobue S; Mizuno Y; Nojiri S; Hirose A; Masuko K; Murasaki G; Fujino N; Nakahara R; Ichikawa T; Itoh M
    Hepatogastroenterology; 2000; 47(32):507-11. PubMed ID: 10791223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence.
    Horigome H; Nomura T; Saso K; Itoh M
    Am J Gastroenterol; 1999 Jul; 94(7):1914-7. PubMed ID: 10406259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
    Yokoi Y; Suzuki S; Baba S; Inaba K; Konno H; Nakamura S
    J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy.
    Seki T; Wakabayashi M; Nakagawa T; Imamura M; Tamai T; Nishimura A; Yamashiki N; Okamura A; Inoue K
    Cancer; 1999 Apr; 85(8):1694-702. PubMed ID: 10223562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma.
    Poon RT; Fan ST; Ng IO; Lo CM; Liu CL; Wong J
    Cancer; 2000 Aug; 89(3):500-7. PubMed ID: 10931448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for extrahepatic metastasis of hepatocellular carcinoma following successful hepatic resection.
    Aramaki M; Kawano K; Kai T; Yokoyama H; Morii Y; Sasaki A; Yoshida T; Kitano S
    Hepatogastroenterology; 1999; 46(29):2931-4. PubMed ID: 10576375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV.
    Wang J; Li Q; Sun Y; Zheng H; Cui Y; Li H; Zhou H; Hao X
    Surg Oncol; 2009 Mar; 18(1):25-30. PubMed ID: 18640032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive multimodality treatment for intra-hepatic recurrence of hepatocellular carcinoma following hepatic resection.
    Chan KM; Lee WC; Hung CF; Yu MC; Jan YY; Chen MF
    Chang Gung Med J; 2005 Aug; 28(8):543-50. PubMed ID: 16265844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and course of small hepatocellular carcinomas in patients with hepatitis C virus types 1 and 2.
    Toyoda H; Kumada T; Nakano S; Takeda I; Sugiyama K; Kiriyama S; Sone Y; Hisanaga Y
    J Med Virol; 2001 Feb; 63(2):120-7. PubMed ID: 11170048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
    Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival.
    Yamakado K; Nakatsuka A; Akeboshi M; Shiraki K; Nakano T; Takeda K
    Oncol Rep; 2004 Jan; 11(1):105-9. PubMed ID: 14654911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
    Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR
    J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
    Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
    Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
    Ueki T; Sakaguchi S; Miyajima Y; Hatono N; Tohara K; Nakabayashi S; Yao T; Kokawa H; Hirano M; Okumura M
    Cancer; 2002 Aug; 95(3):596-604. PubMed ID: 12209753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma.
    Hayashi K; Kumada T; Nakano S; Takeda I; Sugiyama K; Kiriyama S; Sone Y; Miyata A; Shimizu H; Satomura S
    Am J Gastroenterol; 1999 Oct; 94(10):3028-33. PubMed ID: 10520864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
    Ueno H; Okada S; Okusaka T; Ikeda M; Tanaka N; Sakamoto M; Yoshimori M
    Hepatogastroenterology; 2001; 48(41):1430-4. PubMed ID: 11677980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.
    Cucchetti A; Piscaglia F; Caturelli E; Benvegnù L; Vivarelli M; Ercolani G; Cescon M; Ravaioli M; Grazi GL; Bolondi L; Pinna AD
    Ann Surg Oncol; 2009 Feb; 16(2):413-22. PubMed ID: 19034578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
    Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
    Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.